ACC 2025

Late-breaking Heart Failure Studies

Potential benefit of autologous cell therapy in patients with ischaemic HFrEF?

Presented By

Prof. Amish Raval, University of Wisconsin – Madison, WI, USA

Trial

CardiAMP-HF

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:09

Restricting fluid in HF may not be necessary after all

Presented By

Dr Roland van Kimmenade, Radboud University Medical Center, the Netherlands

Trial

FRESH-UP

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:07

FAIR-HF2: The value of intravenous iron in patients with HF and iron deficiency

Presented By

Prof. Stefan Anker, Charité University, Germany

Trial

Phase 4, FAIR-HF2

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:04

MIGHTy-Heart: Can we improve transition-of-care in post-acute HF?

Presented By

Prof. Ruth Masterson Creber, Columbia University, NY, USA

Trial

MIGHTy-Heart

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:03

Dapagliflozin after TAVI reduces HF in elderly patients

Presented By

Dr Sergio Raposeiras-Roubín, Hospital Universitario Álvaro Cunqueiro de Vigo, Spain

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 15:01

Cardiometabolic and Vascular Disease

Oral semaglutide reduces cardiovascular events in patients at high-risk with type 2 diabetes

Presented By

Prof. Darren McGuire, University of Texas, TX, USA

Trial

Phase 3, SOUL

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:46

STRIDE: Semaglutide improves function, symptoms, and outcomes in patients with peripheral artery disease and type 2 diabetes

Presented By

Prof. Marc P. Bonaca, University of Colorado, CO, USA

Trial

Phase 3, STRIDE

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:42

Lorundrostat represents novel class of BP-lowering drugs

Presented By

Dr Luke Laffin, Cleveland Clinic, OH, USA

Trial

Phase 2, Advance-HTN

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:41

ALLEPRE: Long-term benefits of nurse-led secondary prevention programme for ACS

Presented By

Dr Giulia Magnani, University of Parma, Italy

Trial

ALLEPRE

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:39

Can we manage INOCA in women with intensive medical therapy?

Presented By

Prof. Eileen Handberg, University of Florida, FL, USA

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:32

Balancing Ischaemia and Bleeding Risk

API-CAT: Encouraging results for extended reduced-dose apixaban in cancer-related VTE

Presented By

Prof. Isabelle Mahé, Université Paris Cité, France

Trial

Phase 3, API-CAT

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:30

Rivaroxaban may be an alternative to warfarin in post-MI left ventricular thrombus

Presented By

Dr Jehangir Shah, National Institute of Cardiovascular Diseases, Pakistan

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:28

Clopidogrel may be preferred over aspirin in high-risk patients after PCI

Presented By

Dr Joo-Yong Hahn, Sungkyunkwan University School of Medicine, South Korea

Trial

Phase 4, SMART-CHOICE 3

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:25

Potentially practice-changing formulation for cardiac surgery-related bleeding?

Presented By

Dr Keyvan Karkouti, University of Toronto, Canada

Trial

Phase 3, FARES-II, LEX-211

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:23

Searching for the optimal duration of DAPT after PCI

Presented By

Prof. Hyo-Soo Kim, Seoul National University Hospital, South Korea

Trial

HOST-BR

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:22

REVERSE-IT: Bentracimab restores platelet function in ticagrelor users

Presented By

Dr Deepak Bhatt, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

Phase 3, REVERSE-IT

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:20

Developments in Invasive Interventions

More Topics